Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. CbdMD, Inc.
  6. News
  7. Summary
    YCBD   US12482W1018

CBDMD, INC.

(YCBD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

CbdMD : Becomes the Official CBD Partner of NOBULL CrossFit ...

05/04/2021 | 11:07am EDT

cbdMD is proud to become an Official CBD Partner of the NOBULL CrossFit Semifinals and NOBULL CrossFit Games - a unique and challenging athletic event designed to crown the Fittest Man and Fittest Woman on Earth.

While most athletic competitions focus on a specialty with long-established events and criteria, the NOBULL CrossFit Games do things differently. The events change from year to year, and they're kept secret until the last moment to ensure a level playing field for all competitors. The result is a competition that truly reveals the best-conditioned athletes in the world.

Why cbdMD and CrossFit are a Perfect Match

For cbdMD Chairman and Co-CEO Martin Sumichrast, cbdMD's partnership with the NOBULL CrossFit Games is born from common outlooks towards health and wellness.

'Between the physical rigor and prestige of CrossFit among fitness enthusiasts and CrossFit members alike, and cbdMD's reputation as the brand that elite athletes turn to for recovery treatment, we believe that cbdMD and CrossFit are the perfect match,' said Sumichrast.

Fitness and wellness are lifestyle choices. They're not something you're simply born with, becoming your best self requires daily commitment. And this has been cbdMD's message since its founding, and it's a point of view shared by CrossFit athletes at all levels. We're proud to align with the NOBULL CrossFit Games to demonstrate the power of CBD in healthy lifestyles, just as we've done with our esteemed Team cbdMD athletes for years.'

Watch Out for the NOBULL CrossFit Games

The NOBULL CrossFit Semifinals will take place May 28 through June 20, 2021, at 10 in-person events across six continents. Those who advance will compete in the final stage of the competition at the NOBULL CrossFit Games in Madison, Wisconsin, from July 27 to August 1, 2021.

For more information, visit CrossFit.com.

Disclaimer

cbdMD Inc. published this content on 04 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 May 2021 15:06:05 UTC.


ę Publicnow 2021
All news about CBDMD, INC.
06/12CBDMDá : Dealing With Stress? Learn About Why Stress Management Is ...
PU
06/11CBD BATH BOMBS : What Are They and Can You Make Your Own?...
PU
06/10CBDMDá : What is CBD Cream? A Beginner's Guide to CBD Topicals...
PU
06/08NATIONAL PET APPRECIATION WEEK : Why We Love Our Pets...
PU
06/04CBD BODY CARE : A Guide to Our Natural Skin Care Products...
PU
06/04CRAZY DOG AND SEPARATION ISSUES : How Owners Can Help...
PU
06/04CBDMDá : What Causes Snoring? Tips On How To Sleep Better, And Quie...
PU
06/03CBDMDá : Therapeutics Announces Launch Of Animal Health Study In Collaboration W..
BU
06/02CBD FOR CATS : How To Train Your Cat Using CBD Treats...
PU
06/01CBD MYTHS DEBUNKED : Here Are the Facts About CBD...
PU
More news
Financials (USD)
Sales 2021 51,3 M - -
Net income 2021 -27,9 M - -
Net cash 2021 21,9 M - -
P/E ratio 2021 -40,0x
Yield 2021 -
Capitalization 194 M 194 M -
EV / Sales 2021 3,35x
EV / Sales 2022 2,82x
Nbr of Employees 165
Free-Float 63,7%
Chart CBDMD, INC.
Duration : Period :
cbdMD, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CBDMD, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 6,03 $
Last Close Price 3,40 $
Spread / Highest target 135%
Spread / Average Target 77,5%
Spread / Lowest Target 20,6%
EPS Revisions
Managers and Directors
NameTitle
Martin A. Sumichrast Chairman & Co-Chief Executive Officer
Raymond Scott Coffman President, Co-Chief Executive Officer & Director
T. Ronan Kennedy Chief Operating & Financial Officer
Sibyl Swift Vice President-Scientific & Regulatory Affairs
Bakari Sellers Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CBDMD, INC.15.25%194
JOHNSON & JOHNSON4.82%434 405
ROCHE HOLDING AG10.68%328 612
PFIZER, INC.9.07%224 747
NOVARTIS AG-0.39%208 035
ABBVIE INC.7.72%203 857